For: | Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol 2004; 10(3): 404-409 [PMID: 14760767 DOI: 10.3748/wjg.v10.i3.404] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i3/404.htm |
Number | Citing Articles |
1 |
Fanni Rencz, Márta Péntek, Martin Bortlik, Edyta Zagorowicz, Tibor Hlavaty, Andrzej Śliwczyński, Mihai M Diculescu, Limas Kupcinskas, Krisztina B Gecse, László Gulácsi, Peter L Lakatos. Biological therapy in inflammatory bowel diseases: Access in Central and Eastern Europe. World Journal of Gastroenterology 2015; 21(6): 1728-1737 doi: 10.3748/wjg.v21.i6.1728
|
2 |
Z. Vegh, J. Burisch, N. Pedersen, I. Kaimakliotis, D. Duricova, M. Bortlik, S. Avnstrøm, K. Kofod Vinding, J. Olsen, K.R. Nielsen, K.H. Katsanos, E.V. Tsianos, L. Lakatos, D. Schwartz, S. Odes, G. Lupinacci, A. De Padova, L. Jonaitis, L. Kupcinskas, S. Turcan, O. Tighineanu, I. Mihu, L.F. Barros, F. Magro, D. Lazar, A. Goldis, A. Fernandez, V. Hernandez, O. Niewiadomski, S. Bell, E. Langholz, P. Munkholm, P.L. Lakatos. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort. Journal of Crohn's and Colitis 2014; 8(11): 1506 doi: 10.1016/j.crohns.2014.06.004
|
3 |
Aleksandar Vcev, Davorin Pezerovic, Zeljko Jovanovic, Darko Nakic, Ivan Vcev, Ljiljana Majnarić. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010. Wiener klinische Wochenschrift 2015; 127(9-10): 345 doi: 10.1007/s00508-015-0741-7
|
4 |
P. L. Lakatos, S. Fischer, L. Lakatos. Is the epidemiology of inflammatory bowel disease changing in Eastern Europe?. Scandinavian Journal of Gastroenterology 2006; 41(7): 870 doi: 10.1080/00365520600636167
|
5 |
Charlène Duchesne, Patrick Faure, François Kohler, Marie-Pierre Pingannaud, Guillaume Bonnaud, Franck Devulder, Laurent Abramowitz, Christian Boustière, Laurent Peyrin-Biroulet. Management of inflammatory bowel disease in France: A nationwide survey among private gastroenterologists. Digestive and Liver Disease 2014; 46(8): 675 doi: 10.1016/j.dld.2014.04.004
|
6 |
Nicholas J Talley, Maria T Abreu, Jean-Paul Achkar, Charles N Bernstein, Marla C Dubinsky, Stephen B Hanauer, Sunanda V Kane, William J Sandborn, Thomas A Ullman, Paul Moayyedi. An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease. American Journal of Gastroenterology 2011; 106: S2 doi: 10.1038/ajg.2011.58
|
7 |
Panu Wetwittayakhlang, Lorant Gonczi, Petra A. Golovics, Zsuzsanna Kurti, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Laszlo Lakatos, Peter L. Lakatos. Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977–2020. Journal of Clinical Medicine 2023; 12(8): 3026 doi: 10.3390/jcm12083026
|
8 |
Lorant Gonczi, Laszlo Lakatos, Petra A. Golovics, Dorottya Angyal, Fruzsina Balogh, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter L. Lakatos. Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades. Alimentary Pharmacology & Therapeutics 2024; 59(5): 656 doi: 10.1111/apt.17836
|
9 |
J Burisch, N Pedersen, S Čuković-Čavka, M Brinar, I Kaimakliotis, D Duricova, O Shonová, I Vind, S Avnstrøm, N Thorsgaard, V Andersen, S Krabbe, J F Dahlerup, R Salupere, K R Nielsen, J Olsen, P Manninen, P Collin, E V Tsianos, K H Katsanos, K Ladefoged, L Lakatos, E Björnsson, G Ragnarsson, Y Bailey, S Odes, D Schwartz, M Martinato, G Lupinacci, M Milla, A De Padova, R D'Incà, M Beltrami, L Kupcinskas, G Kiudelis, S Turcan, O Tighineanu, I Mihu, F Magro, L F Barros, A Goldis, D Lazar, E Belousova, I Nikulina, V Hernandez, D Martinez-Ares, S Almer, Y Zhulina, J Halfvarson, N Arebi, S Sebastian, P L Lakatos, E Langholz, P Munkholm. East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014; 63(4): 588 doi: 10.1136/gutjnl-2013-304636
|
10 |
Siew C. Ng. Epidemiology of inflammatory bowel disease: Focus on Asia. Best Practice & Research Clinical Gastroenterology 2014; 28(3): 363 doi: 10.1016/j.bpg.2014.04.003
|
11 |
Peter Laszlo Lakatos, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Lajos S. Kiss, Laszlo Lakatos. IBD in the elderly population: Results from a population-based study in Western Hungary, 1977–2008. Journal of Crohn's and Colitis 2011; 5(1): 5 doi: 10.1016/j.crohns.2010.08.004
|
12 |
Jennifer Lee, Pedro M. Moraes-Vieira, Angela Castoldi, Pratik Aryal, Eric U. Yee, Christopher Vickers, Oren Parnas, Cynthia J. Donaldson, Alan Saghatelian, Barbara B. Kahn. Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses
. Journal of Biological Chemistry 2016; 291(42): 22207 doi: 10.1074/jbc.M115.703835
|
13 |
Ryan E. Childers, Swathi Eluri, Christine Vazquez, Rayna Matsuno Weise, Theodore M. Bayless, Susan Hutfless. Family history of inflammatory bowel disease among patients with ulcerative colitis: A systematic review and meta-analysis. Journal of Crohn's and Colitis 2014; 8(11): 1480 doi: 10.1016/j.crohns.2014.05.008
|
14 |
Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Alex Al Khoury, Peter L Lakatos. Declining Trends of Reoperations and Disease Behaviour Progression in Crohn’s Disease over Different Therapeutic Eras—A Prospective, Population-Based Study from Western Hungary between 1977–2020, Data from the Veszprem Cohort. Journal of Crohn's and Colitis 2023; 17(12): 1980 doi: 10.1093/ecco-jcc/jjad117
|
15 |
Cristina Tocia, Anda Carmen Achim, Luana Alexandrescu, E. Dumitru. Inflammatory Bowel Diseases: focus on epidemiology. ARS Medica Tomitana 2017; 23(4): 204 doi: 10.1515/arsm-2017-0038
|
16 |
Gyula Horváth, Zsolt Simonka, György Lázár. Comparison of the results of laparotomy and laparoscopic surgery in patients with Crohn’s disease. Orvosi Hetilap 2014; 155(1): 24 doi: 10.1556/OH.2014.29794
|
17 |
Gilaad G. Kaplan, Joseph W. Windsor. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 2021; 18(1): 56 doi: 10.1038/s41575-020-00360-x
|
18 |
Richard F. A. Logan, Emma L. Armitage. Challenges in Inflammatory Bowel Disease. 2006; : 1 doi: 10.1002/9780470753170.ch1
|
19 |
Seung Wook Hong, Byong Duk Ye. The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia. Intestinal Research 2020; 18(4): 345 doi: 10.5217/ir.2020.00121
|
20 |
Jana Diabelková. Selected environmental risk factors of inflammatory bowel diseases. Hygiena 2018; 63(3): 99 doi: 10.21101/hygiena.a1585
|
21 |
Yaroslava Zhulina, Ruzan Udumyan, Ida Henriksson, Curt Tysk, Scott Montgomery, Jonas Halfvarson. Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: A population-based retrospective study. Journal of Crohn's and Colitis 2014; 8(12): 1653 doi: 10.1016/j.crohns.2014.07.006
|
22 |
S. C. Ng, F. K. L. Chan, J. J. Y. Sung. Review article: the role of non-biological drugs in refractory inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2011; 33(4): 417 doi: 10.1111/j.1365-2036.2010.04541.x
|
23 |
P. L. Lakatos. Pathogenesis and Clinical Practice in Gastroenterology. 2008; 160: 43 doi: 10.1007/978-1-4020-8767-7_6
|
24 |
Peter Laszlo Lakatos. Recent trends in the epidemiology of inflammatory bowel diseases: Up or down?. World Journal of Gastroenterology 2006; 12(38): 6102-6108 doi: 10.3748/wjg.v12.i38.6102
|
25 |
Joye Varghese, K. R. Mohan, I. Haseeb, K. Krishnaprasad, A. Sundaram, V. Jayanthi. Inflammatory Bowel Disease – Is It a Gynaecological Premalignant Lesion? A Case Report. Hungarian Medical Journal 2008; 2(2): 261 doi: 10.1556/HMJ.2.2008.2.11
|
26 |
Edward V. Loftus. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Current Gastroenterology Reports 2004; 6(6): 506 doi: 10.1007/s11894-004-0073-7
|
27 |
Janice J. Kim, Byram W. Bridle, Jean-Eric Ghia, Huaqing Wang, Shahzad N. Syed, Marcus M. Manocha, Palanivel Rengasamy, Mohammad Sharif Shajib, Yonghong Wan, Peter B. Hedlund, Waliul I. Khan. Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation. The Journal of Immunology 2013; 190(9): 4795 doi: 10.4049/jimmunol.1201887
|
28 |
S E Roberts, K Thorne, N Thapar, I Broekaert, M A Benninga, J Dolinsek, E Mas, E Miele, R Orel, C Pienar, C Ribes-Koninckx, M Thomson, C Tzivinikos, S Morrison-Rees, A John, J G Williams. A Systematic Review and Meta-analysis of Paediatric Inflammatory Bowel Disease Incidence and Prevalence Across Europe. Journal of Crohn's and Colitis 2020; 14(8): 1119 doi: 10.1093/ecco-jcc/jjaa037
|
29 |
Peter Laszlo Lakatos, Gabriella Gyori, Judit Halasz, Peter Fuszek, Janos Papp, Balazs Jaray, Peter Lukovich, Laszlo Lakatos. Mucocele of the appendix: An unusual cause of lower abdominal pain in a patient with ulcerative colitis-. A case report and review of literature. World Journal of Gastroenterology 2005; 11(3): 457-459 doi: 10.3748/wjg.v11.i3.457
|
30 |
Bruno César da Silva, Andre Castro Lyra, Raquel Rocha, Genoile Oliveira Santana. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World Journal of Gastroenterology 2014; 20(28): 9458-9467 doi: 10.3748/wjg.v20.i28.9458
|
31 |
|
32 |
|
33 |
Maria Papp, Peter Laszlo Lakatos, Karoly Palatka, Ildiko Foldi, Miklos Udvardy, Jolan Harsfalvi, Istvan Tornai, Zsuzsanna Vitalis, Tamas Dinya, Agota Kovacs, Tamas Molnar, Pal Demeter, Janos Papp, Laszlo Lakatos, Istvan Altorjay. Haptoglobin Polymorphisms Are Associated with Crohn’s Disease, Disease Behavior, and Extraintestinal Manifestations in Hungarian Patients. Digestive Diseases and Sciences 2007; 52(5): 1279 doi: 10.1007/s10620-006-9615-1
|
34 |
David E. Elliott, Joel V. Weinstock. The Hygiene Hypothesis and Darwinian Medicine. 2009; : 149 doi: 10.1007/978-3-7643-8903-1_9
|
35 |
Keqi Yu, Shengtao Liao, Chuanfei Li, Ya Song, Zhechuan Mei, Lin Lv. Establishment of a lipopolysaccharide-induced inflammation model of human fetal colon cells. Molecular Biology Reports 2023; 50(7): 5557 doi: 10.1007/s11033-023-08465-7
|
36 |
|
37 |
Freerk Prenzel, Holm H. Uhlig. Frequency of indeterminate colitis in children and adults with IBD — a metaanalysis. Journal of Crohn's and Colitis 2009; 3(4): 277 doi: 10.1016/j.crohns.2009.07.001
|
38 |
W. Petritsch, S. Fuchs, A. Berghold, G. Bachmaier, C. Högenauer, A.C. Hauer, U. Weiglhofer, H.H. Wenzl. Incidence of inflammatory bowel disease in the province of Styria, Austria, from 1997 to 2007: A population-based study. Journal of Crohn's and Colitis 2013; 7(1): 58 doi: 10.1016/j.crohns.2012.03.012
|
39 |
Peter Laszlo Lakatos, Laszlo Lakatos. Ulcerative proctitis: a review of pharmacotherapy and management. Expert Opinion on Pharmacotherapy 2008; 9(5): 741 doi: 10.1517/14656566.9.5.741
|
40 |
Nicholas A. Braus, David E. Elliott. Advances in the pathogenesis and treatment of IBD. Clinical Immunology 2009; 132(1): 1 doi: 10.1016/j.clim.2009.02.006
|
41 |
Petra A Golovics, Laszlo Lakatos, Michael D Mandel, Barbara D Lovasz, Zsuzsanna Vegh, Zsuzsanna Kurti, Istvan Szita, Lajos S Kiss, Tunde Pandur, Peter L Lakatos. Prevalence and predictors of hospitalization in Crohn’s disease in a prospective population-based inception cohort from 2000-2012. World Journal of Gastroenterology 2015; 21(23): 7272-7280 doi: 10.3748/wjg.v21.i23.7272
|
42 |
Xiaolei Wang, Li Qin, Jingli Cao, Jing Zhao. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn’s disease: a systematic review and meta-analysis. Current Medical Research and Opinion 2016; 32(12): 2007 doi: 10.1080/03007995.2016.1226168
|
43 |
C. M. Smyth, S. Bacheer Picha, O. Rathore, J. Deasy, S. E. Patchett, F. E. Murray. Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996 – 2001. Irish Journal of Medical Science 2005; 174(4): 28 doi: 10.1007/BF03168978
|
44 |
A. Muthukumar, Bhavani Keserla, Syed Mohasin Abbas, Reena Thapa, Rumana Khatija. A Clinical Review on Ulcerative Colitis (Colon Cancer). Research Journal of Pharmacy and Technology 2023; : 6050 doi: 10.52711/0974-360X.2023.00982
|
45 |
Laszlo Lakatos, Lajos S. Kiss, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Peter Laszlo Lakatos. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006. Inflammatory Bowel Diseases 2011; 17(12): 2558 doi: 10.1002/ibd.21607
|
46 |
J. Burisch, N. Pedersen, S. Cukovic-Cavka, N. Turk, I. Kaimakliotis, D. Duricova, M. Bortlik, O. Shonová, I. Vind, S. Avnstrøm, N. Thorsgaard, S. Krabbe, V. Andersen, J.F. Dahlerup, J. Kjeldsen, R. Salupere, J. Olsen, K.R. Nielsen, P. Manninen, P. Collin, K.H. Katsanos, E.V. Tsianos, K. Ladefoged, L. Lakatos, G. Ragnarsson, E. Björnsson, Y. Bailey, C. O'Morain, D. Schwartz, S. Odes, M. Giannotta, G. Girardin, G. Kiudelis, L. Kupcinskas, S. Turcan, L. Barros, F. Magro, D. Lazar, A. Goldis, I. Nikulina, E. Belousova, D. Martinez-Ares, V. Hernandez, S. Almer, Y. Zhulina, J. Halfvarson, N. Arebi, H.H. Tsai, S. Sebastian, P.L. Lakatos, E. Langholz, P. Munkholm. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study. Journal of Crohn's and Colitis 2014; 8(7): 607 doi: 10.1016/j.crohns.2013.11.021
|
47 |
Johan Burisch, Tine Jess, Matteo Martinato, Peter L. Lakatos. The burden of inflammatory bowel disease in Europe. Journal of Crohn's and Colitis 2013; 7(4): 322 doi: 10.1016/j.crohns.2013.01.010
|
48 |
Ziad Kanaan, Surriya Ahmad, Henry Roberts, Tama Thé, Steven Girdler, Jianmin Pan, Shesh N. Rai, E. Brooks Weller, Susan Galandiuk. Crohn’s Disease in Caucasians and African Americans, as Defined by Clinical Predictors and Single Nucleotide Polymorphisms. Journal of the National Medical Association 2012; 104(9-10): 420 doi: 10.1016/S0027-9684(15)30195-4
|
49 |
Ian Logan, Christopher L. Bowlus. The geoepidemiology of autoimmune intestinal diseases. Autoimmunity Reviews 2010; 9(5): A372 doi: 10.1016/j.autrev.2009.11.008
|
50 |
Peter Laszlo Lakatos, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Lajos S. Kiss, Laszlo Lakatos. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008. Journal of Crohn's and Colitis 2011; 5(2): 122 doi: 10.1016/j.crohns.2010.11.005
|
51 |
Péter Kunovszki, Ágnes Milassin, Judit Gimesi-Országh, Péter Takács, Kata Szántó, Anita Bálint, Klaudia Farkas, András Borsi, Péter L. Lakatos, Tamás Szamosi, Tamás Molnár, Valérie Pittet. Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study. PLOS ONE 2020; 15(5): e0233238 doi: 10.1371/journal.pone.0233238
|
52 |
David E. Elliott, Robert W. Summers, Joel V. Weinstock. Helminths as governors of immune-mediated inflammation. International Journal for Parasitology 2007; 37(5): 457 doi: 10.1016/j.ijpara.2006.12.009
|
53 |
Peter Laszlo Lakatos, Simon Fischer, Laszlo Lakatos, Istvan Gal, Janos Papp. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”. World Journal of Gastroenterology 2006; 12(12): 1829-1841 doi: 10.3748/wjg.v12.i12.1829
|
54 |
Airi Jussila, Lauri J. Virta, Hannu Kautiainen, Matti Rekiaro, Urpo Nieminen, Martti A. Färkkilä. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: A nationwide register study in Finland. Inflammatory Bowel Diseases 2012; 18(3): 555 doi: 10.1002/ibd.21695
|
55 |
Joana Torres, Silvio Danese, Jean-Frédéric Colombel. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 2013; 62(11): 1642 doi: 10.1136/gutjnl-2012-303959
|
56 |
Annika Lapidus. Crohn’s disease in Stockholm County during 1990-2001: An epidemiological update. World Journal of Gastroenterology 2006; 12(1): 75-81 doi: 10.3748/wjg.v12.i1.75
|
57 |
Peter Laszlo Lakatos, Petra Anna Golovics, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Agnes Horvath, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Gabor Veres, Barbara Dorottya Lovasz, Miklos Szathmari, Lajos S Kiss, Laszlo Lakatos. Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009. American Journal of Gastroenterology 2012; 107(4): 579 doi: 10.1038/ajg.2011.448
|
58 |
Siliang Liu, Angao Xu, Yanfei Gao, Yue Xie, Zhipeng Liu, Meiling Sun, Hua Mao, Xinying Wang. Graphene oxide exacerbates dextran sodium sulfate-induced colitis via ROS/AMPK/p53 signaling to mediate apoptosis. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00832-5
|
59 |
A. M. El-Tawil. Smoking and inflammatory bowel diseases: what in smoking alters the course?. International Journal of Colorectal Disease 2010; 25(6): 671 doi: 10.1007/s00384-010-0925-6
|
60 |
C. Laclotte, A. Oussalah, P. Rey, M. Bensenane, N. Pluvinage, J.-B. Chevaux, I. Trouilloud, A.-A. Serre, T. Boucekkine, M.-A. Bigard, L. Peyrin-Biroulet. Helminthes et maladies inflammatoires chroniques intestinales. Gastroentérologie Clinique et Biologique 2008; 32(12): 1064 doi: 10.1016/j.gcb.2008.04.030
|
61 |
Jacques Cosnes, Corinne Gower–Rousseau, Philippe Seksik, Antoine Cortot. Epidemiology and Natural History of Inflammatory Bowel Diseases. Gastroenterology 2011; 140(6): 1785 doi: 10.1053/j.gastro.2011.01.055
|
62 |
Peter Laszlo Lakatos, Laszlo Lakatos, Ferenc Szalay, Claudia Willheim-Polli, Christoph Österreicher, Zsolt Tulassay, Tamas Molnar, Walter Reinisch, Janos Papp, Gyula Mozsik, Hungarian IBD Study Group, Peter Ferenci. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn’s disease: Phenotype-genotype correlations. World Journal of Gastroenterology 2005; 11(10): 1489-1495 doi: 10.3748/wjg.v11.i10.1489
|
63 |
Qiyue Wang, Shuyi Mi, Zixuan Yu, Qiyi Li, Jiacai Lei. Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/7397523
|
64 |
Tomas Kupka, Jarmila Simova, Jana Dvorackova, Lubomir Martinek, Oldrich Motyka, Magdalena Uvirova, Petr Dite. Crohn's disease - genetic factors and progress of the disease. Biomedical Papers 2018; 162(2): 139 doi: 10.5507/bp.2017.058
|
65 |
David E. Elliott, Joel V. Weinstock. Helminth–host immunological interactions: prevention and control of immune‐mediated diseases. Annals of the New York Academy of Sciences 2012; 1247(1): 83 doi: 10.1111/j.1749-6632.2011.06292.x
|
66 |
Zsuzsanna Vegh, Zsuzsanna Kurti, Peter L Lakatos. Epidemiology of inflammatory bowel diseases from west to east. Journal of Digestive Diseases 2017; 18(2): 92 doi: 10.1111/1751-2980.12449
|
67 |
Johan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, Svetlana Turcan, Dana Duricova, Martin Bortlik, Karina Winther Andersen, Vibeke Andersen, Ioannis P Kaimakliotis, Mathurin Fumery, Corinne Gower‐Rousseau, Giulia Girardin, Daniela Valpiani, Adrian Goldis, Marko Brinar, Silvija Čuković‐Čavka, Pia Oksanen, Pekka Collin, Luisa Barros, Fernando Magro, Ravi Misra, Naila Arebi, Carl Eriksson, Jonas Halfvarson, Hendrika Adriana Linda Kievit, Natalia Pedersen, Jens Kjeldsen, Sally Myers, Shaji Sebastian, Konstantinos H Katsanos, Dimitrios K Christodoulou, Jóngerð Midjord, Kári Rubek Nielsen, Gediminas Kiudelis, Limas Kupcinskas, Inna Nikulina, Elena Belousova, Doron Schwartz, Selwyn Odes, Riina Salupere, Amalia Carmona, Juan R Pineda, Zsuzsanna Vegh, Peter L Lakatos, Ebbe Langholz, Pia Munkholm. Disease course of inflammatory bowel disease unclassified in a European population‐based inception cohort: An Epi‐IBD study. Journal of Gastroenterology and Hepatology 2019; 34(6): 996 doi: 10.1111/jgh.14563
|
68 |
Pascal Juillerat, Valérie Pittet, Jean-Luc Bulliard, Idris Guessous, Anca Teodora Antonino, Christian Mottet, Christian Felley, John-Paul Vader, Pierre Michetti. Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study. Journal of Crohn's and Colitis 2008; 2(2): 131 doi: 10.1016/j.crohns.2007.10.006
|
69 |
Ferenc Sipos, Orsolya Galamb, László Herszényi, Béla Molnár, Norbert Solymosi, Tamás Zágoni, Lajos Berczi, Zsolt Tulassay. Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis. Scandinavian Journal of Gastroenterology 2008; 43(3): 289 doi: 10.1080/00365520701714434
|
70 |
Bruce E. Sands, Corey A. Siegel. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; : 1941 doi: 10.1016/B978-1-4160-6189-2.00111-6
|
71 |
Jonas Halfvarson, Tine Jess, Anders Magnuson, Scott M. Montgomery, Marianne Orholm, Curt Tysk, Vibeke Binder, Gunnar Järnerot. Environmental factors in inflammatory bowel disease: A co-twin control study of a Swedish-Danish twin population. Inflammatory Bowel Diseases 2006; 12(10): 925 doi: 10.1097/01.mib.0000228998.29466.ac
|
72 |
Ayokunle T Abegunde, Bashir H Muhammad, Owais Bhatti, Tauseef Ali. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World Journal of Gastroenterology 2016; 22(27): 6296-6317 doi: 10.3748/wjg.v22.i27.6296
|
73 |
Jianfeng Cheng. Analysis of Epidemiological and Clinical Characteristics of Inflammatory Bowel Disease over 15- year period. Gastroenterology & Hepatology : Open Access 2015; 2(3) doi: 10.15406/ghoa.2015.02.00041
|
74 |
Cristina Saro Gismera, Beatriz Sicilia Aladrén. Inflammatory bowel diseases: A disease (s) of modern times? Is incidence still increasing?. World Journal of Gastroenterology 2008; 14(36): 5491-5498 doi: 10.3748/wjg.14.5491
|
75 |
Joye Varghese, K. R. Mohan, I. Haseeb, K. Krishnaprasad, A. Sundaram, V. Jayanthi. Association of Cervix Carcinoma and Ulcerative Colitis. A Case Report. Hungarian Medical Journal 2008; 2(3): 463 doi: 10.1556/HMJ.2.2008.3.15
|
76 |
L Lakatos, P L Lakatos. Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?. Postgraduate Medical Journal 2006; 82(967): 332 doi: 10.1136/pgmj.2005.042416
|
77 |
David E. Elliott, Joel V. Weinstock. Pathogen-Derived Immunomodulatory Molecules. Advances in Experimental Medicine and Biology 2009; 666: 157 doi: 10.1007/978-1-4419-1601-3_12
|
78 |
Katalin E. Müller, Péter L. Lakatos, András Arató, Judit B. Kovács, Ágnes Várkonyi, Dániel Szűcs, Erzsébet Szakos, Enikő Sólyom, Márta Kovács, Marianne Polgár, Éva Nemes, Ildikó Guthy, István Tokodi, Gergely Tóth, Ágnes Horváth, András Tárnok, Noémi Csoszánszki, Márta Balogh, Noémi Vass, Piroska Bódi, Antal Dezsőfi, László Gárdos, Éva Micskey, Mária Papp, Áron Cseh, Dolóresz Szabó, Péter Vörös, Gabor Veres. Incidence, Paris Classification, and Follow‐up in a Nationwide Incident Cohort of Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(5): 576 doi: 10.1097/MPG.0b013e31829f7d8c
|
79 |
Barbara D. Lovasz, Petra A. Golovics, Zsuzsanna Vegh, Peter L. Lakatos. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Digestive and Liver Disease 2013; 45(4): 269 doi: 10.1016/j.dld.2012.08.020
|